Buyers fight rise in U.S. drug prices
Pharmaceutical companies have hit a wall of resistance to the practice of continually promoting new drugs typically more expensive ones that are sometimes no better than older ones.
Pharmaceutical companies have hit a wall of resistance to the practice of continually promoting new drugs typically more expensive ones that are sometimes no better than older ones.